Suyzeko Advanced Hydrogen Oxygen Inhaler Wellness Therapy Equipment for Clinic Hydrogen Inhalation Machine

Name: Suyzeko Advanced Hydrogen Oxygen Inhaler Wellness Therapy Equipment for Clinic Hydrogen Inhalation Machine
Brand: Shenzhen Guangyang Zhongkang Technology Co., Ltd.
SKU: 2329214885

Guangdong, ChinaShenzhen Guangyang Zhongkang Technology Co., Ltd.

US$4,580.00

1-9 Pieces

US$3,980.00

10+ Pieces

Product profile

Customization

Available

Application Fields

Medical

Certification

Model NO.

GY-HX6000

Condition

New

Noise Level

Low

Parts

Filters

Purpose

Gas Recovery

Types

Water Electrolysis Hydrogen Production Machine

Product Name

Hydrogen Inhalation Machine

Power

1600W

Hydrogen Flow Rate

4000ml/Min

Oxygen Flow Rate

2000ml/Min

Purity

99.995

Water Capacity

Working Time

30min-8hours

Input Voltage

100-240V

Water Requirements

Purified Water

Feature

LED Touch Screen

Gross Weight

25kg

Machine Size

Medium

Transport Package

Carton Package

Specification

32.5*36*58cm

Trademark

SSCH/Suyzeko

Origin

China

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceR&D CapabilitiesProduct Certification

Shenzhen Guangyang Zhongkang Technology Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableAverage Response Time: ≤8.91h

AI-Powered supplier vetting

SummaryThe supplier demonstrates broad customization and R&D capabilities, including full customization, ODM services, recent product development, and three R&D engineers. Quality and service processes are documented, with ISO9001:2015, CE, and FCC certifications. It has 11 years of export experience, self-operated import/export rights, and exports representing 90% of total sales. Production-related evidence is limited, although the supplier reports OEM service for well-known brands and maintains quality inspection procedures. After-sales support is supported by technical assistance and documented complaint, corrective-action, and preventive-action procedures, but overseas service infrastructure is absent. Financial credibility cannot be assessed because the provided records identify years rather than financial results. Customer evidence includes OEM service for well-known brands and a 50%–80% repeat-buyer preference, but no Fortune 500 cooperation.

CertificationsThe supplier holds an ISO9001:2015 management-system certificate and reports CE and FCC product compliance certifications. These certifications provide explicit evidence of quality-system and product-compliance credentials.

After-Sales capabilityR&D engineers are responsible for technical support during production and after-sales service. The supplier also has documented and followed procedures for customer complaints and corrective and preventive actions, although no overseas warehouse, showroom, agent, or branch is available.

R&D capabilityThe supplier reports new products during the past year, ODM service, three R&D engineers, and responsibilities covering customer requirements, technical support, and new product development. However, it has no available SDK, so its innovation capability is supported for product development but not SDK-based integration.

Production capacityThe supplier reports OEM service for well-known brands, standardized finished-product inspection instructions, written warehouse quality-control procedures with records, two quality-control staff, and one test-equipment unit. These indicate operational and quality-control capability, though detailed production capacity and equipment information is not provided.

Customization capabilityThe supplier explicitly offers customization from samples and designs, full, minor, and flexible customization, together with ODM services. This is strong direct evidence of broad customization capability.

Client casesThe supplier reports OEM service for well-known brands, participation in the CMEF trade show, and a 50%–80% repeat-buyer preference. It reports no Fortune 500 cooperation, so the available customer evidence is positive but does not establish Fortune 500 experience.